You are here

Nestlé Health Science partners with Bioiberica to deliver innovative nutrition in joint health and mobility

16 Jun 2020
  • Nestlé Health Science is incorporating Bioiberica’s patented ingredient, Mobilee®, into its MERITENE® Mobilis® joint-health drink mix
  • Mobilee® is a natural extract containing a high concentration of hyaluronic acid and other components, including collagen and polysaccharides, which have scientifically shown to contribute to the maintenance of joint and muscle health
  • The WHO estimates that by 2050, 130 million people worldwide could suffer from osteoarthritis and mobility problems due to aging and active lifestyles

Nestlé Health Science and Bioiberica are delivering an innovative solution for joint health and mobility through science-based nutritional ingredients. Nestlé Health Science is incorporating Mobilee®, a naturally-derived ingredient developed and patented by Bioiberica, into its  MERITENE® Mobilis®. The product has already been introduced in Italy, with expansion to other markets planned.

MERITENE® Mobilis® is a specifically formulated blend of protein and nutrients that delivers a unique triple action formula to help nourish muscles, bones and joints. The Mobilee® ingredient is a key part of this unique product’s formula – a rooster comb extract that is proven to contribute to the maintenance of joint and muscle health. Mobilee® is naturally rich in hyaluronic acid and other components, including collagen and polysaccharides. Additionally, its nutritional characteristics and safety have been tested in six preclinical trials and five randomised clinical trials over the last twelve years.

“Leveraging Bioiberica’s Mobilee® ingredient helps us continue to bring innovative, science-based nutrition to consumers and patients with mobility concerns. Nestlé Health Science is committed to elevating the role of nutrition in helping people on their journey to age healthily. By supporting their ability to maintain their independence, we can help empower people to age the way they want”, explains Rick Jentis, Global Head of the Healthy Aging Category at Nestlé Health Science.”

“Joint health has become a major public health concern worldwide, largely due to an aging population. According to the World Health Organization (WHO), an estimated 130 million people worldwide will suffer from osteoarthritis – a degenerative disease associated with aging and one of the leading causes of disability around the globe – by 2050. That makes mobility a strategic area for both companies and a key focus for our new developments and products,” explains Jaume Reguant, director of Bioiberica Healthcare.

He continues: “The partnership with Nestlé Health Science allows us to combine over 40 years’ of experience in treating osteoarthritis and joint health and our specialist knowledge in the development, production and marketing of value-added ingredients from natural origin and, with the leadership and expertise of Nestlé Health Science to offer innovative products that support mobility and quality of life through nutrition".

Mobilee® is authorised as an ingredient for nutritional or dietary use by the main competent authorities worldwide, such as the European Union (Novel Food), Canada (medicinal supplement), United States (self-affirmed GRAS status) Australia and New Zealand (medicinal supplement and non-traditional ingredient for use in functional foods), Brazil (Novel Food), India (functional ingredient), Indonesia and Taiwan (nutritional supplement),


Nestlé Health Science (NHSc), a wholly-owned subsidiary of Nestlé, is a globally recognized leader in the field of nutritional science. At NHSc we are committed to empowering healthier lives through nutrition for consumers, patients and their healthcare partners. We offer an extensive consumer health portfolio of industry-leading medical nutrition, consumer and VMS brands that are science-based solutions covering all facets of health from prevention, to maintenance, all the way through to treatment. NHSc is redefining the way we approach the management of health in several key areas such as pediatric health, allergy, acute care, oncology, metabolic health, healthy aging, gastrointestinal health, and inborn errors of metabolism. Headquartered in Switzerland, NHSc employs over 5,000 people around the world, who are committed to making a difference in people’s lives, for a healthier today and tomorrow

Bioiberica is a global Life Science company committed to improving people, animal, and plant health and well-being. Bioiberica is a leading Heparin API manufacturer and a world reference in the research, production, and sale of other pharmaceutical and nutraceutical ingredients like chondroitin sulfate, glucosamine, hyaluronic acid, native type II collagen, and thyroid.